로딩 중…
지수 로딩 중…
Bausch Health Companies Inc.
BHC· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CA
$7.00+1.60%
2026-08-03
Financials
Valuation Metrics
Bausch Health Companies Inc.'s Market Cap is $2.61B. At end of 2025 it was $2.58B. Ranked #1872 of 3,111 in US market (top 60%), #1186 of 1,666 on NYSE (top 71%), #113 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 42%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.61B | US#1,872/3,111 Sec#113/269 |
| Revenue | $9.82B | US#563/3,111 Sec#20/269 |
| Net Income | $-1.08B | US—/3,111 Sec—/269 |
| Total Assets | $24.79B | US#548/3,111 Sec#21/269 |
| Net Assets | $-1.77B | US#3,062/3,111 Sec#272/269 |
| Value | ||
| P/S | 0.27x | US#115/3,111 Sec#1/269 |
| EV/EBITDA | 1.45x | US#970/3,111 Sec#31/269 |
| FCF Yield | 54.76% | US#44/3,111 Sec#1/269 |
| Profitability | ||
| ROA | -4.36% | US#2,521/3,111 Sec#93/269 |
| Op. Margin | 27.43% | US#754/3,111 Sec#37/269 |
| Revenue Growth | -28.53% | US#1,266/3,111 Sec#93/269 |
| Earnings Growth | 71.39% | US—/3,111 Sec—/269 |
| Financial Health | ||
| Total Debt | $866M | US#227/3,111 Sec#15/269 |
| FCF | $1.43B | US#575/3,111 Sec#24/269 |
| Cash | $900M | US#573/3,111 Sec#30/269 |
| Current Ratio | 0.20x | US#1,857/3,111 Sec#252/269 |
| Net Debt/EBITDA | -0.02x | US#2,368/3,111 Sec#90/269 |
| Performance | ||
| 1Y Return | 22.59% | US#1,508/3,111 Sec#170/269 |
| 1M Return | 42.86% | US#13/3,111 Sec#2/269 |
| From 52W High | -19.45% | US#1,699/3,111 Sec#118/269 |
| 1Y MDD | -46.88% | US#2,269/3,111 Sec#175/269 |
| Trading | ||
| Volume | 9,006,566 shares | US#95/3,111 Sec#7/269 |
| Trading Value | $63M | US#834/3,111 Sec#50/269 |
| Per Share | ||
| EPS | $0.42 | US#1,877/3,111 Sec#64/269 |